Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -2.25% | 175.49 | 0.7% | $1348.91m | |
| MRK | Merck & Co., Inc. | -1.44% | 91.09 | 0.7% | $1211.42m | |
| PFE | Pfizer Inc. | -3.20% | 50.64 | 0.9% | $1081.72m | |
| LLY | Eli Lilly & Co. | -1.19% | 320.85 | 1.1% | $1023.75m | |
| BMY | Bristol-Myers Squibb Co. | -2.40% | 75.00 | 1.0% | $981.18m | |
| ABBV | AbbVie, Inc. | -2.11% | 150.55 | 1.9% | $950.23m | |
| AZN | AstraZeneca Plc | -1.87% | 64.72 | 1.0% | $458.04m | |
| SGEN | Seagen Inc. | -2.89% | 174.91 | 5.7% | $328.36m | |
| GSK | GSK Plc | -2.22% | 42.78 | 0.2% | $272.62m | |
| TPTX | Turning Point Therapeutics, Inc. | 0.07% | 75.17 | 0.0% | $203.00m | |
| HZNP | Horizon Therapeutics Plc | 2.01% | 82.47 | 5.4% | $174.03m | |
| NVS | Novartis AG | -1.09% | 83.44 | 0.2% | $170.72m | |
| MRTX | Mirati Therapeutics, Inc. | -2.60% | 69.33 | 1.6% | $148.80m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | -0.52% | 147.48 | 8.1% | $148.60m | |
| NVO | Novo Nordisk A/S | -2.02% | 109.39 | 0.1% | $139.08m |
Company Profile
SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline include galinpepimut-S and nelipepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.